Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the field of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and therapy are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering potential for more successful treatment o